(MSDL) Morgan Stanley Direct - Overview
Stock: Corporate Bonds, Middle-Market Debt, Acquisition Financing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 11.32% |
| Yield on Cost 5y | 12.00% |
| Yield CAGR 5y | -9.09% |
| Payout Consistency | 97.0% |
| Payout Ratio | 1.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.1% |
| Relative Tail Risk | -8.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.04 |
| Alpha | -29.21 |
| Character TTM | |
|---|---|
| Beta | 0.571 |
| Beta Downside | 0.602 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.21% |
| CAGR/Max DD | -0.18 |
Description: MSDL Morgan Stanley Direct January 16, 2026
Morgan Stanley Direct Lending Fund (NYSE: MSDL) is a Business Development Company that primarily provides senior secured loans to middle-market companies and private-equity sponsors financing acquisitions, positioning itself in the higher-risk segment of the corporate bond market.
As of the latest filing, the fund manages roughly $1.2 billion in assets, targets a net asset-yield of 8-10 % and maintains an average portfolio duration of 4-5 years, reflecting sensitivity to the current 4-5 % U.S. Treasury curve. Its performance is closely tied to the health of the U.S. middle-market economy, with loan growth historically correlating to GDP expansion rates of 2-3 % and to private-equity deal flow, which has surged 15 % YoY in 2024.
For a deeper, data-driven look at how MSDL’s risk-adjusted returns compare to peers, you might explore the fund’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 145.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -1.85 > 1.0 |
| NWC/Revenue: 7.22% < 20% (prev 14.24%; Δ -7.01% < -1%) |
| CFO/TA 0.00 > 3% & CFO 13.1m > Net Income 145.0m |
| Net Debt (-65.5m) to EBITDA (147.2m): -0.44 < 3 |
| Current Ratio: 1.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (86.8m) vs 12m ago -2.71% < -2% |
| Gross Margin: 52.65% > 18% (prev 0.64%; Δ 5200 % > 0.5%) |
| Asset Turnover: 7.43% > 50% (prev 8.73%; Δ -1.30% > 0%) |
| Interest Coverage Ratio: 1.08 > 6 (EBITDA TTM 147.2m / Interest Expense TTM 136.0m) |
Altman Z'' 0.28
| A: 0.01 (Total Current Assets 95.4m - Total Current Liabilities 74.6m) / Total Assets 3.93b |
| B: -0.00 (Retained Earnings -7.91m / Total Assets 3.93b) |
| C: 0.04 (EBIT TTM 147.2m / Avg Total Assets 3.86b) |
| D: -0.00 (Book Value of Equity -7.82m / Total Liabilities 2.16b) |
| Altman-Z'' Score: 0.28 = B |
What is the price of MSDL shares?
Over the past week, the price has changed by -6.30%, over one month by -9.37%, over three months by -5.89% and over the past year by -18.28%.
Is MSDL a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MSDL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.5 | 15.5% |
| Analysts Target Price | 17.5 | 15.5% |
| ValueRay Target Price | 16.5 | 8.5% |
MSDL Fundamental Data Overview February 03, 2026
P/E Forward = 8.547
P/S = 9.4109
P/B = 0.7943
Revenue TTM = 287.2m USD
EBIT TTM = 147.2m USD
EBITDA TTM = 147.2m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.97b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -65.5m USD (from netDebt column, last quarter)
Enterprise Value = 3.31b USD (1.41b + Debt 1.97b - CCE 65.5m)
Interest Coverage Ratio = 1.08 (Ebit TTM 147.2m / Interest Expense TTM 136.0m)
EV/FCF = 252.4x (Enterprise Value 3.31b / FCF TTM 13.1m)
FCF Yield = 0.40% (FCF TTM 13.1m / Enterprise Value 3.31b)
FCF Margin = 4.57% (FCF TTM 13.1m / Revenue TTM 287.2m)
Net Margin = 50.49% (Net Income TTM 145.0m / Revenue TTM 287.2m)
Gross Margin = 52.65% ((Revenue TTM 287.2m - Cost of Revenue TTM 136.0m) / Revenue TTM)
Gross Margin QoQ = 47.59% (prev 52.48%)
Tobins Q-Ratio = 0.84 (Enterprise Value 3.31b / Total Assets 3.93b)
Interest Expense / Debt = 1.72% (Interest Expense 33.9m / Debt 1.97b)
Taxrate = 1.44% (402.0k / 28.0m)
NOPAT = 145.1m (EBIT 147.2m * (1 - 1.44%))
Current Ratio = 1.28 (Total Current Assets 95.4m / Total Current Liabilities 74.6m)
Debt / Equity = 1.11 (Debt 1.97b / totalStockholderEquity, last quarter 1.77b)
Debt / EBITDA = -0.44 (Net Debt -65.5m / EBITDA 147.2m)
Debt / FCF = -4.99 (Net Debt -65.5m / FCF TTM 13.1m)
Total Stockholder Equity = 1.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.75% (Net Income 145.0m / Total Assets 3.93b)
RoE = 8.03% (Net Income TTM 145.0m / Total Stockholder Equity 1.81b)
RoCE = 3.82% (EBIT 147.2m / Capital Employed (Total Assets 3.93b - Current Liab 74.6m))
RoIC = 3.79% (NOPAT 145.1m / Invested Capital 3.83b)
WACC = 4.33% (E(1.41b)/V(3.38b) * Re(8.02%) + D(1.97b)/V(3.38b) * Rd(1.72%) * (1-Tc(0.01)))
Discount Rate = 8.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.92%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈41.1m ; Y1≈26.9m ; Y5≈12.3m
Fair Price DCF = 5.27 (EV 391.8m - Net Debt -65.5m = Equity 457.3m / Shares 86.8m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -88.79 | EPS CAGR: -71.77% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.08 | Revenue CAGR: 20.77% | SUE: -1.13 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.48 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=7
EPS next Year (2026-12-31): EPS=1.86 | Chg30d=+0.004 | Revisions Net=+1 | Growth EPS=-8.2% | Growth Revenue=-7.7%